CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,185,988
- in 8 filings, $4.8M under 10b5-1 plans
Net −$5,185,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-06 | Lukatch Heath Director | Grant or award | +1,550 | 7,175 | ||
| 2024-06-06 | Lukatch Heath Director | Grant or award · Stock Option (right to buy) | +7,250 | 7,250 | ||
| 2024-06-06 | Drapeau Anne S Director | Grant or award | +1,550 | 7,175 | ||
| 2024-06-06 | Drapeau Anne S Director | Grant or award · Stock Option (right to buy) | +7,250 | 7,250 | ||
| 2024-06-06 | Hirth Peter Director | Grant or award | +1,550 | 7,175 | ||
| 2024-06-06 | Hirth Peter Director | Grant or award · Stock Option (right to buy) | +7,250 | 7,250 | ||
| 2024-06-06 | Paya Carlos V Director | Grant or award | +1,550 | 4,050 | ||
| 2024-06-06 | Paya Carlos V Director | Grant or award · Stock Option (right to buy) | +7,250 | 7,250 | ||
| 2024-06-03 | Gilbert Halley E Director | Option exercise 10b5-1 | +18,200 | $5.35 | $97K | 23,825 |
| 2024-06-03 | Gilbert Halley E Director | Sale 10b5-1 | −18,200 | $73.00 | $1.3M | 5,625 |
| 2024-06-03 | Gilbert Halley E Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −18,200 | 30,374 | ||
| 2024-06-03 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Option exercise 10b5-1 | +1,667 | $21.41 | $36K | 32,828 |
| 2024-06-03 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −751 | $71.25 | $54K | 32,077 |
| 2024-06-03 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −656 | $72.37 | $47K | 31,421 |
| 2024-06-03 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −260 | $73.64 | $19K | 31,161 |
| 2024-06-03 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Option exercise · Stock Option (right to buy) 10b5-1 | −1,667 | 184,998 | ||
| 2024-06-03 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −1,634 | $71.38 | $117K | 214,869 |
| 2024-06-03 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −906 | $72.32 | $66K | 213,964 |
| 2024-06-03 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −460 | $73.48 | $34K | 213,503 |
| 2024-06-03 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −705 | $71.44 | $50K | 145,349 |
Page 27 of 39 · 764 trades